Peter M. Hecht - Mar 25, 2025 Form 4 Insider Report for Cyclerion Therapeutics, Inc. (CYCN)

Role
Director, 10%+ Owner
Signature
/s/ Peter M. Hecht
Stock symbol
CYCN
Transactions as of
Mar 25, 2025
Transactions value $
$500,000
Form type
4
Date filed
3/27/2025, 08:38 PM
Previous filing
Jan 26, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYCN Common Stock Award $500K +182K +48.18% $2.75 559K Mar 25, 2025 Direct F1
holding CYCN Common Stock 24 Mar 25, 2025 The 2000 Trust for Alexis Mae Hecht F2
holding CYCN Common Stock 24 Mar 25, 2025 The 2000 Trust for Malcolm Peter Hecht F2
holding CYCN Common Stock 24 Mar 25, 2025 The 2000 Trust for Zoe Niovi Hecht F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 25, 2025, the reporting person purchased directly from the Issuer 181,818 shares of Common Stock for a total purchase price of approximately $500,000 (or $2.75 per share) in a private placement transaction pursuant to the Stock Purchase Agreement dated as of March 21, 2025 by and among the Issuer and the investors named therein.
F2 These shares are held in the referenced trust for the benefit of the reporting person's child. The reporting person's spouse is the trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or any other purpose.